complex generics

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!DIVISLAB Q3 2024-2025 Call Highlights: Expansion Plans, Generics Growth, and API Challenges!

Divi's Laboratories Ltd., an Indian multinational pharmaceutical company that manufactures and exports API's, Intermediates and Nutraceutical ingredients, in its Q3…

Piramal Pharma Ltd Q2FY25; 360% rise in Profits

Piramal Pharma Ltd Q2FY25; 360% rise in ProfitsPiramal Pharma Ltd Q2FY25; 360% rise in Profits

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1)…